LITS
Lite Strategy, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+9.62%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-107.0%
Return on equity
-105.2%
Return on assets
-22.4%
Return on invested capital
0.00x
Asset turnover
-$10.4M
Cash from operations
$0.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026